The new interim president of Harvard has been accused of having potential conflicts of interest due to his roles on the boards of two major pharmaceutical companies, for which he is paid $1million annually.Alan Garber is earning more from his board membership roles than his full-time gig as, a position that earned him $946,000 in 2022. explains his salary padding is not uncommon among professors, many of whom earn more from sitting on the boards of large, for-profit firms than from their university salaries.
Load More
Load More